Hims & Hers on Saturday said it would stop offering its copycat Wegovy weight-loss pill. The decision comes after Novo Nordisk, maker of Wegovy, and the U.S. Food and Drug Administration threatened ...

The FDA announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new compounded semaglutide (Wegovy) weight-loss ...

Hims & Hers Health (HIMS) fell ~8% in the premarket on Friday after FDA Commissioner Marty Makary said that his agency will take swift action against “companies mass-marketing illegal copycat drugs.” ...

Novo Nordisk, maker of Wegovy, saw its stock rise 6.5% after the opening bell on Monday. The company and the U.S. Food and Drug Administration threatened legal action against Hims & Hers, over its ...

A box of Wegovy pills at a pharmacy in Provo, Utah, US. Just two days after launching a copycat version Wegovy’s new weight-loss pill, Hims & Hers Health Inc. said it will stop selling the drug.

Wegovy and Ozempic maker Novo Nordisk NOVO.B-1.05%decrease; red down pointing triangle filed a lawsuit against Hims & Hers as it seeks a ban on the telehealth provider offering copycat versions of the ...

Not even two days after Novo Nordisk A/S pinned its comeback hopes on a new weight-loss pill that’s off to a strong start, a knock-off version is already on the market that the Danish drugmaker says ...

Hims & Hers scrapped plans Saturday to sell a $49 knockoff of Novo Nordisk’s Wegovy weight-loss pill, one day after the online telehealth company was threatened with legal action by the U.S. Food and ...

Feb 5 (Reuters) - The U.S. Food and Drug Administration (FDA) will take swift action against companies that mass-market "illegal copycat drugs" by claiming they are similar to FDA-approved products, ...

Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. The US drug regulator plans to crack down on copycat versions of popular weight-loss drugs sold by Hims & ...

Add Yahoo as a preferred source to see more of our stories on Google. U.S. Food and Drug Administration Commissioner Marty Makary speaks during a press conference at the Department of Health and Human ...